Cargando…
Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology
OBJECTIVE: The highly conserved 14‐3‐3 proteins interact with key players involved in Parkinson's disease (PD) and other neurodegenerative disorders. We recently demonstrated that 14‐3‐3 phosphorylation is increased in PD models and that increased 14‐3‐3 phosphorylation reduces the neuroprotect...
Autores principales: | McFerrin, Michael B., Chi, Xiaofei, Cutter, Gary, Yacoubian, Talene A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497531/ https://www.ncbi.nlm.nih.gov/pubmed/28695147 http://dx.doi.org/10.1002/acn3.421 |
Ejemplares similares
-
14-3-3 phosphorylation inhibits 14-3-3θ’s ability to regulate LRRK2 kinase activity
por: Pattanayak, Rudradip, et al.
Publicado: (2023) -
14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer’s Disease Mouse Models
por: Gannon, Mary, et al.
Publicado: (2022) -
14-3-3theta Protects against Neurotoxicity in a Cellular Parkinson's Disease Model through Inhibition of the Apoptotic Factor Bax
por: Slone, Sunny R., et al.
Publicado: (2011) -
14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
por: Underwood, Rachel, et al.
Publicado: (2021) -
Interleukin-1 mediates Alzheimer and Lewy body pathologies
por: Griffin, W Sue T, et al.
Publicado: (2006)